UNSPSC 51461527: Pygeum africanum

This classification denotes a natural product which US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 709HYI14M4, the source of which US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O05WS7301S, the source of which the Integrated Taxonomic Information System classifies under Taxonomic Serial Number 837327 as a member of Kingdom Plantae, Subkingdom Viridaeplantae, Infrakingdom Streptophyta, Division Tracheophyta, Subdivision Spermatophytina, Infradivision Angiospermae, Class Magnoliopsida, Superorder Rosanae, Order Rosales, Family Rosaceae, Genus Prunus L. (chokecherry, plum), Species Prunus africana, often commonly called RED STINKWOOD or as here, PRUNUS AFRICANA.

UNSPSC 51461527 Pygeum africanum is a Commodity code covering pharmaceutical active ingredients and botanical compounds for use in multi-source generic and over-the-counter product formulations supplied to state and local government facilities. State and local procurement under this code centers on establishing framework agreements with manufacturers to supply raw pharmaceutical materials and finished goods through authorized wholesale distribution networks. Issuing bodies include state cooperative purchasing alliances and their participating member agencies — state departments, counties, municipalities, school districts, and other public facilities — that rely on multi-state cooperative vehicles to aggregate demand and negotiate standardized pricing and terms.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued a Request for Proposal in January 2026 (S1070000015802) to establish multiple contracts for generic multi-source pharmaceuticals and over-the-counter products effective July 1, 2026, with proposals due March 26, 2026. The procurement requires vendors to supply products through three authorized wholesalers — AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC — and mandates submission of comprehensive product information including National Drug Codes, SKUs, UPCs, generic descriptions, strength, dosage form, trade names, and packaging configurations. Vendors must certify compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act, maintain relationships with at least two of the three authorized wholesalers with chargeback systems in place, and carry commercial general liability insurance of at least $5 million per occurrence. Evaluation is weighted heavily toward price competitiveness (75 percent) and fixed pricing (10 percent), with lesser weight on EDI capability, administrative fee format compliance, and agreement to a 3 percent administrative fee (5 percent each). The contract term is two years for new responders with optional extensions, or aligned through June 30, 2028 for incumbent responders.